🚨 JUST IN: $AQST
Aquestive resubmits Anaphylm NDA to FDA; addresses CRL with positive human factor/PK data

#SEC #stocks #investing #AQST #Regulatory
🔗 secwatch.observer

#AQST Aquestive Therapeutics Announces Resubmission of New Drug Application to FDA for Anaphylm™ (dibutepinephrine) Sublingual Film

https://www.stocktitan.net/news/AQST/aquestive-therapeutics-announces-resubmission-of-new-drug-6gfyo8qaujum.html?utm_source=stocktitan-bluesky&utm_medium=social